BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 9477112)

  • 1. Urologic tumors in the Federal Republic of Germany: data on 56,013 cases from hospital cancer registries.
    Fischer CG; Waechter W; Kraus S; Fuentecilla Perez E; Weidner W; Dudeck J
    Cancer; 1998 Feb; 82(4):775-83. PubMed ID: 9477112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Urologic tumors in Germany. Initial data of 56,013 cases from clinical cancer registers].
    Fischer CG; Wächter W; Fuentecilla Perez E; Miller J; Weidner W; Dudeck J
    Urologe A; 1997 Mar; 36(2):143-50. PubMed ID: 9199042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal cell carcinoma invading the urinary collecting system: implications for staging.
    Uzzo RG; Cherullo E; Myles J; Novick AC
    J Urol; 2002 Jun; 167(6):2392-6. PubMed ID: 11992044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surveillance of urothelial carcinoma: stage and grade migration, 1993-2005 and survival trends, 1993-2000.
    David KA; Mallin K; Milowsky MI; Ritchey J; Carroll PR; Nanus DM
    Cancer; 2009 Apr; 115(7):1435-47. PubMed ID: 19215030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genitourinary tumor following kidney transplantation: a multicenter study.
    Einollahi B; Simforoosh N; Lessan-Pezeshki M; Basiri A; Nafar M; Pour-Reza Gholi F; Firouzan A; Ahmadpour P; Makhdomi K; Ghafari A; Taghizadeh A; Tayebi Khosroshahi H
    Transplant Proc; 2009 Sep; 41(7):2848-9. PubMed ID: 19765454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tumor markers in the histopathology of urologic tumors].
    Hofstädter F
    Urologe A; 1987 Jan; 26(1):2-6. PubMed ID: 3576859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laparoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma: results of a Belgian retrospective multicentre survey.
    Schatteman P; Chatzopoulos C; Assenmacher C; De Visscher L; Jorion JL; Blaze V; Van Cleynenbreugel B; Billiet I; Van der Eecken H; Bollens R; Mottrie A
    Eur Urol; 2007 Jun; 51(6):1633-8; discussion 1638. PubMed ID: 17055638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreasing size at diagnosis of stage 1 renal cell carcinoma: analysis from the National Cancer Data Base, 1993 to 2004.
    Cooperberg MR; Mallin K; Ritchey J; Villalta JD; Carroll PR; Kane CJ
    J Urol; 2008 Jun; 179(6):2131-5. PubMed ID: 18423754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laparoscopic radical nephroureterectomy for upper tract transitional cell carcinoma: oncological outcomes at 7 years.
    Berger A; Haber GP; Kamoi K; Aron M; Desai MM; Kaouk JH; Gill IS
    J Urol; 2008 Sep; 180(3):849-54; discussion 854. PubMed ID: 18635229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unusual clinical presentation of upper urothelial carcinoma in Taiwan.
    Chou YH; Huang CH
    Cancer; 1999 Mar; 85(6):1342-4. PubMed ID: 10189140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic impact of p63 and p53 expression in upper urinary tract transitional cell carcinoma.
    Zigeuner R; Tsybrovskyy O; Ratschek M; Rehak P; Lipsky K; Langner C
    Urology; 2004 Jun; 63(6):1079-83. PubMed ID: 15183954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The protective role of renal parenchyma as a barrier to local tumor spread of upper tract transitional cell carcinoma and its impact on patient survival.
    Park J; Ha SH; Min GE; Song C; Hong B; Hong JH; Kim CS; Ahn H
    J Urol; 2009 Sep; 182(3):894-9. PubMed ID: 19616243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary tract cancer and hereditary nonpolyposis colorectal cancer: risks and screening options.
    Sijmons RH; Kiemeney LA; Witjes JA; Vasen HF
    J Urol; 1998 Aug; 160(2):466-70. PubMed ID: 9679899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical review of conservative management of upper urinary tract transitional cell carcinoma].
    Oka H; Shiraishi Y; Negoro H; Iwamura H; Moroi S; Soeda A; Takeuchi H; Kawakita M
    Hinyokika Kiyo; 2006 Apr; 52(4):249-53. PubMed ID: 16686350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray.
    Higgins JP; Kaygusuz G; Wang L; Montgomery K; Mason V; Zhu SX; Marinelli RJ; Presti JC; van de Rijn M; Brooks JD
    Am J Surg Pathol; 2007 May; 31(5):673-80. PubMed ID: 17460449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of C-reactive protein in urological cancers: a useful biomarker for predicting outcomes.
    Saito K; Kihara K
    Int J Urol; 2013 Feb; 20(2):161-71. PubMed ID: 22897628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Synchronous triple urogenital cancer (renal cancer, bladder cancer, prostatic cancer): a case report].
    Takada T; Honda M; Momohara C; Komori K; Fujioka H
    Hinyokika Kiyo; 2002 Apr; 48(4):239-42. PubMed ID: 12048939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urologic cancer in China.
    Pang C; Guan Y; Li H; Chen W; Zhu G
    Jpn J Clin Oncol; 2016 Jun; 46(6):497-501. PubMed ID: 27049022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical studies on renal pelvic and ureteral tumors].
    Yoshida T; Kajita Y; Iwaki H; Mori H; Yamauchi T
    Hinyokika Kiyo; 2000 Feb; 46(2):77-81. PubMed ID: 10769793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Multiple urologic tumors in autopsy material].
    Tiszlavicz L; Szalay I
    Orv Hetil; 1993 Mar; 134(11):577-81. PubMed ID: 8446411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.